Life science professionals are invited to attend the 2nd Omnichannel Marketing Strategy Symposium on September 29-30, 2022. Pharmaceutical, biotechnology, and medical device companies are realizing the growing importance of a powerful omnichannel marketing campaign that allows pharma to reach the right people at the right time. This intensifies the need for a substantial marketing plan. Taking into account previous impact and consumer data, marketers can concentrate on promotional spending to optimize their investment.
But the vital question is, do marketers in the pharma sphere possess adequate technology and data necessary to make their omnichannel marketing as successful as it could be…
To learn more, please visit https://ibn.fm/NOGfD.
About InvestorWire
InvestorWire is the wire service that gives you more. From regional releases to global announcements presented in multiple languages, we offer the wire-grade dissemination products you’ll need to ensure that your next press release grabs the attention of your target audience and doesn’t let go. While our competitors look to nickel and dime you with hidden fees and restrictive word limits, InvestorWire keeps things transparent. We offer UNLIMITED Words on all domestic releases. While other wire services may provide a basic review of your release, InvestorWire helps you put your best foot forward with complimentary Press Release Enhancement.
With our competitors, the work is done the second your release crosses the wire. Not with InvestorWire. We include follow-up coverage of every release by leveraging the ever-expanding audiences of the 50+ brands that make up the InvestorBrandNetwork.
Get more out of your next press release with InvestorWire. It’s unlike anything you’ve seen before.
For more information, please visit https://www.InvestorWire.com
Please see full terms of use and disclaimers on the InvestorBrandNetwork website applicable to all content provided by IBN, wherever published or re-published: http://ibn.fm/Disclaimer
InvestorWire (IW)
8033 Sunset Blvd Suite 1037-IW
Los Angeles, CA 90046
310.299.1717 Office
www.InvestorWire.com
[email protected]
InvestorWire is part of the InvestorBrandNetwork.